Literature DB >> 12690643

Brain metastases.

Andrew B Lassman1, Lisa M DeAngelis.   

Abstract

Brain metastases are one of the most feared complications of cancer because even small tumors may cause incapacitating neurologic symptoms. This article reviews the epidemiology, clinical features, treatment, and prognosis of brain metastases from system malignancies.

Entities:  

Mesh：

Year:  2003        PMID： 12690643     DOI： 10.1016/s0733-8619(02)00035-x

Source DB:  PubMed          Journal:  Neurol Clin        ISSN： 0733-8619            Impact factor:   3.806


  75 in total

1.  Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.

Authors:  Hee-Jun Kim; Seock-Ah Im; Bhumsuk Keam; Yu-Jung Kim; Sae-Won Han; Tae Min Kim; Do-Youn Oh; Jee Hyun Kim; Se-Hoon Lee; Eui Kyu Chie; Wonshik Han; Dong-Wan Kim; Tae-You Kim; Dong-Young Noh; Dae Seog Heo; In Ae Park; Yung-Jue Bang; Sung Whan Ha
Journal:  J Neurooncol       Date:  2011-09-22       Impact factor: 4.130

2.  Accurate classification of metastatic brain tumors using a novel microRNA-based test.

Authors:  Wolf C Mueller; Yael Spector; Tina Bocker Edmonston; Brianna St Cyr; Diana Jaeger; Ulrike Lass; Ranit Aharonov; Shai Rosenwald; Ayelet Chajut
Journal:  Oncologist       Date:  2011-01-27

3.  Penfluridol: An Antipsychotic Agent Suppresses Metastatic Tumor Growth in Triple-Negative Breast Cancer by Inhibiting Integrin Signaling Axis.

Authors:  Alok Ranjan; Parul Gupta; Sanjay K Srivastava
Journal:  Cancer Res       Date:  2015-12-01       Impact factor: 12.701

4.  A plea for the elective inclusion of the brain in routine whole-body FDG PET.

Authors:  Tarik Belhocine; Stefan Markus Weiner; Ingo Brink; Peter Paul De Deyn; Jan Roland; Thierry Van der Borght; Patrick Flamen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

5.  Systemic high-dose intravenous methotrexate for central nervous system metastases.

Authors:  Andrew B Lassman; Lauren E Abrey; Gaurav D Shah; Gaurav G Shah; Katherine S Panageas; Martin Begemann; Mark G Malkin; Jeffrey J Raizer
Journal:  J Neurooncol       Date:  2006-07       Impact factor: 4.130

6.  Intracranial cystic metastases from breast cancer.

Authors:  Gabriel Rodrigues; Manishka Jayasundera; Raghunath Prabhu
Journal:  Eurasian J Med       Date:  2012-04

7.  Progression of the lung cancer primary correlates with the identification of new brain metastases after initial radiosurgery.

Authors:  Jung Ho Han; Dong Gyu Kim; Chang Wan Oh; Chae-Yong Kim; Young Hoon Kim; Jeong Hoon Park; Eun Kyung Kim; Hee-Won Jung
Journal:  J Neurooncol       Date:  2011-07-06       Impact factor: 4.130

Review 8.  Motexafin gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer.

Authors:  Sayana R Thomas; Deepak Khuntia
Journal:  Int J Nanomedicine       Date:  2007

9.  A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer.

Authors:  T Neuhaus; Y Ko; R P Muller; G G Grabenbauer; J P Hedde; H Schueller; M Kocher; S Stier; R Fietkau
Journal:  Br J Cancer       Date:  2009-01-06       Impact factor: 7.640

10.  Role of KCNMA1 gene in breast cancer invasion and metastasis to brain.

Authors:  Divya Khaitan; Umesh T Sankpal; Babette Weksler; Edward A Meister; Ignacio A Romero; Pierre-Olivier Couraud; Nagendra S Ningaraj
Journal:  BMC Cancer       Date:  2009-07-29       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.